z-logo
open-access-imgOpen Access
Mitchell-Riley syndrome iPSC exhibit reduced pancreatic endoderm differentiation due to an RFX6 mutation
Author(s) -
Jamie Trott,
Yunus Alpagu,
Ee Kim Tan,
Mohammad Shboul,
Yousif Dawood,
Michael Elsy,
Heike Wollmann,
Vincent Tano,
Carine Bonnard,
Shermaine Zi Hui Eng,
Gunaseelan Narayanan,
Seetanshu Junnarkar,
Stephen J. Wearne,
James Strutt,
Aakash Kumar,
Lucian B. Tomaz,
Pierre-Alexis Goy,
Slim Mzoughi,
Rachel Jennings,
Jaco Hagoort,
Ascia Eskin,
Hane Lee,
Stanley F. Nelson,
Fawaz Alkazaleh,
Mohammad El-Khateeb,
Rajaa Fathallah,
H. Shah,
J. Goeke,
Sarah R. Langley,
Ernesto Guccione,
Neil A. Hanley,
Bernadette S. de Bakker,
Bruno Reversade,
N. Ray Dunn
Publication year - 2020
Publication title -
development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.15
H-Index - 36
eISSN - 1477-9129
pISSN - 0950-1991
DOI - 10.1242/dev.194878
Subject(s) - endoderm , pdx1 , biology , pancreas , endocrinology , cellular differentiation , medicine , mutation , homeobox , microbiology and biotechnology , genetics , gene , gene expression , insulin , islet
Mitchell-riley syndrome (MRS) is caused by recessive mutations in the Regulatory Factor X, 6 (RFX6) gene and is characterised by pancreatic hypoplasia and neonatal diabetes. To determine why MRS patients specifically lack pancreatic endocrine cells, we micro-CT imaged a 12-week old foetus homozygous for the nonsense mutation RFX6 c.1129C>T, which revealed loss of the pancreas body and tail. From this foetus, we derived iPSC and show that differentiation of these cells in vitro proceeds normally until generation of pancreatic endoderm, which is significantly reduced. We additionally generated an RFX6HA reporter allele by gene targeting in wild-type H9 cells to precisely define RFX6 expression and in parallel performed in situ hybridization for RFX6 in the dorsal pancreatic bud of a Carnegie Stage 14 human embryo. Both in vitro and in vivo, we find that RFX6 specifically labels a subset of PDX1-expressing pancreatic endoderm. In summary, RFX6 is essential for efficient differentiation of pancreatic endoderm, and its absence in MRS patients specifically impairs formation of endocrine cells of the pancreas head and tail.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here